Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - New York Stock Exchange, Inc. - US10948C1071 - Common Stock - Currency: USD

15.7  +0.55 (+3.63%)

After market: 14.92 -0.78 (-4.97%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BV. BV was compared to 83 industry peers in the Commercial Services & Supplies industry. While BV seems to be doing ok healthwise, there are quite some concerns on its profitability. BV has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BV had positive earnings in the past year.
In the past year BV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BV reported negative net income in multiple years.
BV had a positive operating cash flow in each of the past 5 years.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV's Return On Assets of -0.05% is in line compared to the rest of the industry. BV outperforms 43.37% of its industry peers.
BV's Return On Equity of -0.10% is in line compared to the rest of the industry. BV outperforms 45.78% of its industry peers.
BV has a Return On Invested Capital (2.95%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for BV is significantly below the industry average of 11.67%.
The 3 year average ROIC (2.40%) for BV is below the current ROIC(2.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROIC 2.95%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

BV's Profit Margin has declined in the last couple of years.
The Operating Margin of BV (4.50%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BV has declined.
Looking at the Gross Margin, with a value of 23.23%, BV is doing worse than 67.47% of the companies in the same industry.
In the last couple of years the Gross Margin of BV has declined.
Industry RankSector Rank
OM 4.5%
PM (TTM) N/A
GM 23.23%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BV is destroying value.
The number of shares outstanding for BV has been increased compared to 1 year ago.
The number of shares outstanding for BV has been reduced compared to 5 years ago.
Compared to 1 year ago, BV has an improved debt to assets ratio.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.57, we must say that BV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.57, BV is doing worse than 68.67% of the companies in the same industry.
BV has a debt to FCF ratio of 8.01. This is a slightly negative value and a sign of low solvency as BV would need 8.01 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.01, BV is in the better half of the industry, outperforming 62.65% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that BV is not too dependend on debt financing.
BV has a Debt to Equity ratio of 0.45. This is comparable to the rest of the industry: BV outperforms 55.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.01
Altman-Z 1.57
ROIC/WACC0.37
WACC8.03%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BV has a Current Ratio of 1.42. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV's Current ratio of 1.42 is on the low side compared to the rest of the industry. BV is outperformed by 60.24% of its industry peers.
A Quick Ratio of 1.42 indicates that BV should not have too much problems paying its short term obligations.
BV has a Quick ratio (1.42) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.26% over the past year.
Measured over the past years, BV shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.19% on average per year.
BV shows a decrease in Revenue. In the last year, the revenue decreased by -2.85%.
Measured over the past years, BV shows a small growth in Revenue. The Revenue has been growing by 2.85% on average per year.
EPS 1Y (TTM)5.26%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%27.27%
Revenue 1Y (TTM)-2.85%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-1.53%

3.2 Future

The Earnings Per Share is expected to grow by 15.68% on average over the next years. This is quite good.
Based on estimates for the next years, BV will show a small growth in Revenue. The Revenue will grow by 2.61% on average per year.
EPS Next Y15.36%
EPS Next 2Y14.91%
EPS Next 3Y15.68%
EPS Next 5YN/A
Revenue Next Year0.77%
Revenue Next 2Y1.86%
Revenue Next 3Y2.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.62, the valuation of BV can be described as rather expensive.
Based on the Price/Earnings ratio, BV is valued a bit cheaper than 67.47% of the companies in the same industry.
When comparing the Price/Earnings ratio of BV to the average of the S&P500 Index (27.45), we can say BV is valued slightly cheaper.
A Price/Forward Earnings ratio of 15.85 indicates a correct valuation of BV.
Based on the Price/Forward Earnings ratio, BV is valued a bit cheaper than the industry average as 72.29% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, BV is valued a bit cheaper.
Industry RankSector Rank
PE 19.62
Fwd PE 15.85
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BV is valued a bit cheaper than 78.31% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 73.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.99
EV/EBITDA 7.86
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

BV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BV's earnings are expected to grow with 15.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y14.91%
EPS Next 3Y15.68%

0

5. Dividend

5.1 Amount

No dividends for BV!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (7/3/2025, 7:06:23 PM)

After market: 14.92 -0.78 (-4.97%)

15.7

+0.55 (+3.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners67.56%
Inst Owner Change-1.08%
Ins Owners3.05%
Ins Owner Change0.44%
Market Cap1.50B
Analysts81.11
Price Target20.46 (30.32%)
Short Float %8.15%
Short Ratio6.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-1988.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.9%
Min EPS beat(2)1.9%
Max EPS beat(2)21.9%
EPS beat(4)2
Avg EPS beat(4)4.4%
Min EPS beat(4)-4.54%
Max EPS beat(4)21.9%
EPS beat(8)4
Avg EPS beat(8)-2%
EPS beat(12)6
Avg EPS beat(12)7.72%
EPS beat(16)7
Avg EPS beat(16)3.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-4.84%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-2.51%
Min Revenue beat(4)-4.84%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-2.5%
Revenue beat(16)3
Avg Revenue beat(16)-1.65%
PT rev (1m)4.15%
PT rev (3m)4.15%
EPS NQ rev (1m)-0.67%
EPS NQ rev (3m)-3.48%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 19.62
Fwd PE 15.85
P/S 0.55
P/FCF 14.99
P/OCF 6.04
P/B 0.85
P/tB N/A
EV/EBITDA 7.86
EPS(TTM)0.8
EY5.1%
EPS(NY)0.99
Fwd EY6.31%
FCF(TTM)1.05
FCFY6.67%
OCF(TTM)2.6
OCFY16.56%
SpS28.64
BVpS18.56
TBVpS-3.44
PEG (NY)1.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROCE 4.36%
ROIC 2.95%
ROICexc 3.11%
ROICexgc 14.3%
OM 4.5%
PM (TTM) N/A
GM 23.23%
FCFM 3.66%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 8.01
Debt/EBITDA 2.91
Cap/Depr 97.88%
Cap/Sales 5.42%
Interest Coverage 1.98
Cash Conversion 90.41%
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 1.57
F-Score4
WACC8.03%
ROIC/WACC0.37
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.26%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%27.27%
EPS Next Y15.36%
EPS Next 2Y14.91%
EPS Next 3Y15.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.85%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-1.53%
Revenue Next Year0.77%
Revenue Next 2Y1.86%
Revenue Next 3Y2.61%
Revenue Next 5YN/A
EBIT growth 1Y4.42%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year78.32%
EBIT Next 3Y26.64%
EBIT Next 5YN/A
FCF growth 1Y195.27%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y107.19%
OCF growth 3Y11.48%
OCF growth 5Y3.91%